IMA
Price
$5.95
Change
-$0.04 (-0.67%)
Updated
Jun 23, 03:56 PM (EDT)
Capitalization
66.21M
45 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$2.70
Change
-$0.00 (-0.00%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.88M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMA vs SLXN

IMA vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMA vs. SLXN commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Hold and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (IMA: $5.87 vs. SLXN: $2.71)
Brand notoriety: IMA and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 21% vs. SLXN: 6%
Market capitalization -- IMA: $66.21M vs. SLXN: $2.88M
IMA [@Biotechnology] is valued at $66.21M. SLXN’s [@Biotechnology] market capitalization is $2.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMA is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • IMA’s TA Score: 5 bullish, 3 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMA is a better buy in the short-term than SLXN.

Price Growth

IMA (@Biotechnology) experienced а +5.96% price change this week, while SLXN (@Biotechnology) price change was -1.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

IMA is expected to report earnings on Aug 07, 2026.

SLXN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMA($66.2M) has a higher market cap than SLXN($2.88M). IMA YTD gains are higher at: -14.928 vs. SLXN (-85.885). SLXN has higher annual earnings (EBITDA): -12.91M vs. IMA (-53.41M). IMA has more cash in the bank: 117M vs. SLXN (2.41M). SLXN has less debt than IMA: SLXN (1.99M) vs IMA (2.42M). IMA (0) and SLXN (0) have equivalent revenues.
IMASLXNIMA / SLXN
Capitalization66.2M2.88M2,298%
EBITDA-53.41M-12.91M414%
Gain YTD-14.928-85.88517%
P/E RatioN/A0.00-
Revenue00-
Total Cash117M2.41M4,849%
Total Debt2.42M1.99M121%
TECHNICAL ANALYSIS
Technical Analysis
IMASLXN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
35%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
31%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 12 days ago
54%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IMA
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRGT4.410.60
+15.75%
Freight Technologies Inc.
DGII68.66-0.40
-0.58%
Digi International
FLGT17.85-0.15
-0.83%
Fulgent Genetics
WULF28.31-0.67
-2.31%
TeraWulf
SEV2.27-0.10
-4.22%
Aptera Motors Corp

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-2.17%
CELC - IMA
78%
Closely correlated
+2.47%
SLXN - IMA
62%
Loosely correlated
-0.73%
MNOV - IMA
28%
Poorly correlated
-0.76%
RNAZ - IMA
21%
Poorly correlated
+6.38%
PVLA - IMA
7%
Poorly correlated
+5.08%
More